轻度至中度性结肠炎患者表达的情绪:一项描述性研究
Shaini Suraj1,2, Anand Prakash3,4, Pradeep Patil5
1Amity Institute of Behavioural and Allied Sciences, Amity University Rajasthan, Jaipur, Rajasthan, India.
Annals of neurosciences
|May 5, 2025
概括
性结肠炎 (UC) 患者表达的情绪 (EE) 高,表明家庭环境压力很大. 家庭咨询等干预措施可以改善UC患者的情绪调节.
科学领域:
- 胃肠病学 胃肠病学
- 心理学 心理学 心理学
- 健康科学 卫生科学 卫生科学
背景情况:
- 性结肠炎 (UC) 是一种自身免疫性疾病,具有复发和缓解的特征.
- 表达的情绪 (EE) 被确定为与疾病复发相关的重要压力因素.
- 这项研究调查了EE对被诊断患有UC的个体的影响.
研究的目的:
- 量化患有轻度至中度UC的患者的EE水平.
- 确定人口统计学变量 (年龄,性别,教育,婚姻状况,SES) 与UC患者的EE水平是否相关.
主要方法:
- 采用了一种定量,描述性的调查研究设计.
- 这项研究包括100名参与者 (50名男性,50名女性),年龄在30-50岁之间.
- 家庭情绪参与和批评量表 (FEICS) 测量了被认为的批评 (PC) 和情绪参与 (EI);使用推断统计和千平方测试.
主要成果:
- 在UC患者中,平均PC得分为14.87,平均EI得分为17.24 (分别为28分).
- 总平均EE分数为32.11,表明表达的情绪水平很高.
- 在这个队列中,人口统计学变量和EE水平之间没有发现显著的关联.
结论:
- 患有UC的患者表现出中度的批评,但在他们的家庭中表现出高度的情感参与.
- 家庭咨询和精神教育是推的干预措施,以改善UC患者的家庭环境.
- 改善家庭应对技巧,压力管理和沟通可以帮助UC患者的情绪调节.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102
Inflammatory Bowel Disease I: Ulcerative Colitis
93
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
93
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
223
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
223
Chronic Bowel Disorders: Introduction
300
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
300
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
62
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
62
Inflammatory Bowel Disease II: Crohn's Disease
124
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
124


